LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 20

Search options

  1. Book ; Online ; Thesis: Ursprünge epigenetischer Veränderungen in tumorartigen neuroendokrinen Zellen

    Lahtz, Christoph

    2010  

    Author's details vorgelegt von Christoph Lahtz
    Language German
    Size Online-Ressource
    Document type Book ; Online ; Thesis
    Thesis / German Habilitation thesis Gießen, Univ., Diss., 2010
    Database Library catalogue of the German National Library of Science and Technology (TIB), Hannover

    More links

    Kategorien

  2. Book ; Online ; Thesis: Ursprünge epigenetischer Veränderungen in tumorartigen neuroendokrinen Zellen

    Lahtz, Christoph [Verfasser]

    2010  

    Author's details vorgelegt von Christoph Lahtz
    Keywords Biowissenschaften, Biologie ; Life Science, Biology
    Subject code sg570
    Language German
    Document type Book ; Online ; Thesis
    Database Digital theses on the web

    More links

    Kategorien

  3. Article ; Online: Epigenetic changes of DNA repair genes in cancer.

    Lahtz, Christoph / Pfeifer, Gerd P

    Journal of molecular cell biology

    2011  Volume 3, Issue 1, Page(s) 51–58

    Abstract: Every Hour Hurts, The Last One Kills'. That is an old saying about getting old. Every day, thousands of DNA damaging events take place in each cell of our body, but efficient DNA repair systems have evolved to prevent that. However, our DNA repair ... ...

    Abstract 'Every Hour Hurts, The Last One Kills'. That is an old saying about getting old. Every day, thousands of DNA damaging events take place in each cell of our body, but efficient DNA repair systems have evolved to prevent that. However, our DNA repair system and that of most other organisms are not as perfect as that of Deinococcus radiodurans, for example, which is able to repair massive amounts of DNA damage at one time. In many instances, accumulation of DNA damage has been linked to cancer, and genetic deficiencies in specific DNA repair genes are associated with tumor-prone phenotypes. In addition to mutations, which can be either inherited or somatically acquired, epigenetic silencing of DNA repair genes may promote tumorigenesis. This review will summarize current knowledge of the epigenetic inactivation of different DNA repair components in human cancer.
    MeSH term(s) Animals ; DNA/genetics ; DNA Damage ; DNA Repair/genetics ; Epigenesis, Genetic ; Humans ; Neoplasms/genetics
    Chemical Substances DNA (9007-49-2)
    Language English
    Publishing date 2011-01-30
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 2500949-7
    ISSN 1759-4685 ; 1674-2788
    ISSN (online) 1759-4685
    ISSN 1674-2788
    DOI 10.1093/jmcb/mjq053
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis.

    Aftabizadeh, Maryam / Li, Yi-Jia / Zhao, Qianqian / Zhang, Chunyan / Ambaye, Nigus / Song, Jieun / Nagao, Toshikage / Lahtz, Christoph / Fakih, Marwan / Ann, David K / Yu, Hua / Herrmann, Andreas

    JCI insight

    2021  Volume 6, Issue 2

    Abstract: To date, there are no inhibitors that directly and specifically target activated STAT3 and c-Myc in the clinic. Although peptide-based inhibitors can selectively block activated targets, their clinical usage is limited because of low cell penetration and/ ...

    Abstract To date, there are no inhibitors that directly and specifically target activated STAT3 and c-Myc in the clinic. Although peptide-based inhibitors can selectively block activated targets, their clinical usage is limited because of low cell penetration and/or serum stability. Here, we generated cell-penetrating acetylated (acet.) STAT3, c-Myc, and Gp130 targeting peptides by attaching phosphorothioated (PS) polymer backbone to peptides. The cell-penetrating peptides efficiently penetrated cells and inhibited activation of the intended targets and their downstream genes. Locally or systemically treating tumor-bearing mice with PS-acet.-STAT3 peptide at low concentrations effectively blocked STAT3 in vivo, resulting in significant antitumor effects in 2 human xenograft models. Moreover, PS-acet.-STAT3 peptide penetrated and activated splenic CD8+ T cells in vitro. Treating immune-competent mice bearing mouse melanoma with PS-acet.-STAT3 peptide inhibited STAT3 in tumor-infiltrating T cells, downregulating tumor-infiltrating CD4+ T regulatory cells while activating CD8+ T effector cells. Similarly, systemic injections of the cell-penetrating c-Myc and Gp130 peptides prevented pancreatic tumor growth and induced antitumor immune responses. Taken together, we have developed therapeutic peptides that effectively and specifically block challenging cancer targets, resulting in antitumor effects through both direct tumor cell killing and indirectly through antitumor immune responses.
    MeSH term(s) Acetylation ; Animals ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/pharmacology ; Cell Line, Tumor ; Cell-Penetrating Peptides/chemistry ; Cell-Penetrating Peptides/pharmacology ; Cytokine Receptor gp130/chemistry ; Drug Design ; HCT116 Cells ; Humans ; Lymphocytes, Tumor-Infiltrating/drug effects ; Lymphocytes, Tumor-Infiltrating/immunology ; Melanoma, Experimental/drug therapy ; Melanoma, Experimental/immunology ; Melanoma, Experimental/metabolism ; Mice ; Mice, Inbred C57BL ; Pancreatic Neoplasms/drug therapy ; Peptide Fragments/chemistry ; Peptide Fragments/pharmacology ; Protein Multimerization ; Proto-Oncogene Proteins c-myc/chemistry ; Proto-Oncogene Proteins c-myc/pharmacology ; STAT3 Transcription Factor/antagonists & inhibitors ; STAT3 Transcription Factor/chemistry ; Xenograft Model Antitumor Assays
    Chemical Substances Antineoplastic Agents ; Cell-Penetrating Peptides ; MYC protein, human ; Peptide Fragments ; Proto-Oncogene Proteins c-myc ; STAT3 Transcription Factor ; STAT3 protein, human ; Stat3 protein, mouse ; Cytokine Receptor gp130 (133483-10-0)
    Language English
    Publishing date 2021-01-25
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.136176
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: An effective cell-penetrating antibody delivery platform.

    Herrmann, Andreas / Nagao, Toshikage / Zhang, Chunyan / Lahtz, Christoph / Li, Yi-Jia / Yue, Chanyu / Mülfarth, Ronja / Yu, Hua

    JCI insight

    2019  Volume 4, Issue 14

    Abstract: Despite their well-recognized success in the clinic, antibodies generally do not penetrate cellular membranes to target intracellular molecules, many of which underlie incurable diseases. Here we show that covalently conjugating phosphorothioated DNA ... ...

    Abstract Despite their well-recognized success in the clinic, antibodies generally do not penetrate cellular membranes to target intracellular molecules, many of which underlie incurable diseases. Here we show that covalently conjugating phosphorothioated DNA oligonucleotides to antibodies enabled their efficient cellular internalization. Antibody cell penetration was partially mediated by membrane potential alteration. Moreover, without an antigen to bind, intracellular levels of the modified antibodies underwent cellular clearance, which involved efflux and lysosomal degradation, enabling detection of intended intracellular molecules as tested in fibroblasts, tumor cells, and T cells. This target-dependent cellular retention of modified antibodies extended to in vivo studies. Both local and systemic administrations of low doses of modified antibodies effectively inhibited intracellular targets, such as transcription factors Myc, interferon regulatory factor 4, and tyrosine-protein kinase SRC, and expression of their downstream genes in tumors, resulting in tumor cell apoptosis and tumor growth inhibition. This simple modification enables the use of antibodies to detect and modulate intracellular molecules in both cultured living cells and in whole animals, forming the foundation for a new paradigm for antibody-based research, diagnostics, and therapeutics.
    MeSH term(s) Animals ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/chemistry ; Cell Line, Tumor ; Cell Membrane Permeability/drug effects ; Drug Delivery Systems/methods ; Humans ; Immunoconjugates/administration & dosage ; Immunoconjugates/chemistry ; Immunoconjugates/pharmacology ; Melanoma/drug therapy ; Melanoma/pathology ; Mice ; Oligodeoxyribonucleotides/chemistry ; Oligodeoxyribonucleotides/pharmacology ; Xenograft Model Antitumor Assays
    Chemical Substances Antibodies, Monoclonal ; Immunoconjugates ; Oligodeoxyribonucleotides
    Language English
    Publishing date 2019-07-25
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.127474
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis

    Maryam Aftabizadeh / Yi-Jia Li / Qianqian Zhao / Chunyan Zhang / Nigus Ambaye / Jieun Song / Toshikage Nagao / Christoph Lahtz / Marwan Fakih / David K. Ann / Hua Yu / Andreas Herrmann

    JCI Insight, Vol 6, Iss

    2021  Volume 2

    Abstract: To date, there are no inhibitors that directly and specifically target activated STAT3 and c-Myc in the clinic. Although peptide-based inhibitors can selectively block activated targets, their clinical usage is limited because of low cell penetration and/ ...

    Abstract To date, there are no inhibitors that directly and specifically target activated STAT3 and c-Myc in the clinic. Although peptide-based inhibitors can selectively block activated targets, their clinical usage is limited because of low cell penetration and/or serum stability. Here, we generated cell-penetrating acetylated (acet.) STAT3, c-Myc, and Gp130 targeting peptides by attaching phosphorothioated (PS) polymer backbone to peptides. The cell-penetrating peptides efficiently penetrated cells and inhibited activation of the intended targets and their downstream genes. Locally or systemically treating tumor-bearing mice with PS-acet.-STAT3 peptide at low concentrations effectively blocked STAT3 in vivo, resulting in significant antitumor effects in 2 human xenograft models. Moreover, PS-acet.-STAT3 peptide penetrated and activated splenic CD8+ T cells in vitro. Treating immune-competent mice bearing mouse melanoma with PS-acet.-STAT3 peptide inhibited STAT3 in tumor-infiltrating T cells, downregulating tumor-infiltrating CD4+ T regulatory cells while activating CD8+ T effector cells. Similarly, systemic injections of the cell-penetrating c-Myc and Gp130 peptides prevented pancreatic tumor growth and induced antitumor immune responses. Taken together, we have developed therapeutic peptides that effectively and specifically block challenging cancer targets, resulting in antitumor effects through both direct tumor cell killing and indirectly through antitumor immune responses.
    Keywords Oncology ; Therapeutics ; Medicine ; R
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher American Society for Clinical investigation
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Integrin α6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells.

    Herrmann, Andreas / Lahtz, Christoph / Song, Jieun / Aftabizadeh, Maryam / Cherryholmes, Gregory A / Xin, Hong / Adamus, Tomasz / Lee, Heehyoung / Grunert, David / Armstrong, Brian / Chu, Peiguo / Brown, Christine / Lim, Michael / Forman, Stephen / Yu, Hua

    Oncogene

    2019  Volume 39, Issue 10, Page(s) 2156–2169

    Abstract: Both the extracellular matrix (ECM) and DNA epigenetic regulation are critical for maintaining stem cell phenotype and cancer progression. Whether and how ECM regulates epigenetic alterations to influence cancer stem cells (CSCs) remain to be explored. ... ...

    Abstract Both the extracellular matrix (ECM) and DNA epigenetic regulation are critical for maintaining stem cell phenotype and cancer progression. Whether and how ECM regulates epigenetic alterations to influence cancer stem cells (CSCs) remain to be explored. Here we report that ECM through laminin-integrin α6 upregulates ten-eleven translocation enzyme 3 (TET3) dioxygenase. TET3 in turn mediates DNA cytosine 5'-hydroxymethylation (5hmC) and upregulates genes critical for maintenance of glioma stem cells (GSCs). Activating integrin α6-FAK pathway increases STAT3 activity, TET3 expression and 5hmC levels in GSCs. Moreover, targeting STAT3 disrupts integrin α6-FAK signaling and inhibits TET3
    MeSH term(s) 5-Methylcytosine ; Animals ; Cell Line ; DNA Methylation ; Dioxygenases/genetics ; Dioxygenases/metabolism ; Epigenesis, Genetic ; Female ; Gene Expression Regulation, Neoplastic ; Glioma/enzymology ; Glioma/genetics ; Glioma/metabolism ; Humans ; Integrin alpha6/metabolism ; Male ; Mice, Nude ; Neoplastic Stem Cells/enzymology ; Neoplastic Stem Cells/metabolism ; STAT3 Transcription Factor/metabolism ; Signal Transduction
    Chemical Substances Integrin alpha6 ; STAT3 Transcription Factor ; STAT3 protein, human ; 5-Methylcytosine (6R795CQT4H) ; TET3 protein, human (EC 1.-) ; Dioxygenases (EC 1.13.11.-)
    Language English
    Publishing date 2019-12-09
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 639046-8
    ISSN 1476-5594 ; 0950-9232
    ISSN (online) 1476-5594
    ISSN 0950-9232
    DOI 10.1038/s41388-019-1134-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: UVB irradiation does not directly induce detectable changes of DNA methylation in human keratinocytes.

    Lahtz, Christoph / Kim, Sang-In / Bates, Steven E / Li, Arthur X / Wu, Xiwei / Pfeifer, Gerd P

    F1000Research

    2013  Volume 2, Page(s) 45

    Abstract: Unprotected exposure to UVB radiation from the sun and the resulting DNA damage are thought to be responsible for physiological changes in the skin and for a variety of skin cancers, including basal cell and squamous cell carcinoma and malignant melanoma. ...

    Abstract Unprotected exposure to UVB radiation from the sun and the resulting DNA damage are thought to be responsible for physiological changes in the skin and for a variety of skin cancers, including basal cell and squamous cell carcinoma and malignant melanoma. Although the mutagenic effects of UVB have been well documented and studied mechanistically, there is only limited information as to whether UV light may also be responsible for inducing epigenetic changes in the genome of exposed cells. DNA methylation is a stable epigenetic modification involved in gene control. To study the effects of UVB radiation on DNA methylation, we repeatedly exposed normal human keratinocytes to a UVB light source. After a recovery period, we analyzed global DNA methylation patterns in the irradiated and control cells using the methylated-CpG island recovery assay (MIRA) method in combination with high-resolution microarrays. Bioinformatics analysis revealed only a limited number of possible differences between UVB-exposed and control cells. However, these minor apparent changes could not be independently confirmed by bisulfite sequencing-based approaches. This study reveals that UVB irradiation of keratinocytes has no recognizable global effect on DNA methylation patterns and suggests that changes in DNA methylation, as observed in skin cancers, are not immediate consequences of human exposure to solar UVB irradiation.
    Language English
    Publishing date 2013-02-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 2699932-8
    ISSN 2046-1402
    ISSN 2046-1402
    DOI 10.12688/f1000research.2-45.v1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Methylation of PTEN as a prognostic factor in malignant melanoma of the skin.

    Lahtz, Christoph / Stranzenbach, René / Fiedler, Eckhard / Helmbold, Peter / Dammann, Reinhard H

    The Journal of investigative dermatology

    2010  Volume 130, Issue 2, Page(s) 620–622

    MeSH term(s) DNA Methylation ; Disease Progression ; Disease-Free Survival ; Epigenesis, Genetic ; Gene Expression Regulation, Neoplastic ; Humans ; Melanoma/diagnosis ; Melanoma/genetics ; Melanoma/metabolism ; Mutation ; PTEN Phosphohydrolase/genetics ; Point Mutation ; Prognosis ; Promoter Regions, Genetic ; Proportional Hazards Models ; Skin Neoplasms/diagnosis ; Skin Neoplasms/genetics ; Skin Neoplasms/metabolism
    Chemical Substances PTEN Phosphohydrolase (EC 3.1.3.67) ; PTEN protein, human (EC 3.1.3.67)
    Language English
    Publishing date 2010-02
    Publishing country United States
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 80136-7
    ISSN 1523-1747 ; 0022-202X
    ISSN (online) 1523-1747
    ISSN 0022-202X
    DOI 10.1038/jid.2009.226
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A Targeted Vaccine against COVID-19: S1-Fc Vaccine Targeting the Antigen-Presenting Cell Compartment Elicits Protection against SARS-CoV-2 Infection

    Herrmann, Andreas / Maruyama, Junki / Yue, Chanyu / Lahtz, Christoph / Zhou, Heyue / Kerwin, Lisa / Guo, Whenzong / Zhang, Yanliang / Hoo, William Soo / Yei, Soonpin / Kwon, Sunkuk / Fu, Yanwen / Johnson, Sachi / Ledesma, Arthur / Zhou, Yiran / Zhuang, Yingcong / Yei, Elena / Adamus, Tomasz / Praessler, Slobodan /
    Ji, Henry

    bioRxiv

    Abstract: Vaccination efficacy is enhanced by targeting the antigen-presenting cell compartment. Here, we show that S1-Fc antigen delivery targeting the FcγR+ antigen-presenting cell compartment elicits anti-SARS-CoV-2 S1-antigen specific IgG production in vivo ... ...

    Abstract Vaccination efficacy is enhanced by targeting the antigen-presenting cell compartment. Here, we show that S1-Fc antigen delivery targeting the FcγR+ antigen-presenting cell compartment elicits anti-SARS-CoV-2 S1-antigen specific IgG production in vivo exerting biologically functional and protective activity against live virus infection, assessed in a stringent experimental virus challenge assay in vitro. The S1-domain of the SARS-CoV-2 spike protein was genetically fused to a human immunoglobulin Fc moiety, which contributes to mediate S1-Fc cellular internalization by FcγR+ antigen-presenting cells. Immediately upon administration intramuscularly, our novel vaccine candidate recombinant rS1-Fc homes to lymph nodes in vivo where FcγR+ antigen-presenting cells reside. Seroconversion is achieved as early as day 7, mounting considerably increased levels of anti-S1 IgGs in vivo. Interestingly, immunization at elevated doses with non-expiring S1-Fc encoding dsDNA favors the education of a desired antigen-specific adaptive T cell response. However, low-dose immunization, safeguarding patient safety, using recombinant rS1-Fc, elicits a considerably elevated protection amplitude against live SARS-CoV-2 infection. Our promising findings on rS1-Fc protein immunization prompted us to further develop an affordable and safe product for delivery to our communities in need for COVID-19 vaccinations.
    Keywords covid19
    Publisher BioRxiv; WHO
    Document type Article ; Online
    DOI 10.1101/2020.06.29.178616
    Database COVID19

    Kategorien

To top